|
⚲
|
| Qrxpharma Ltd | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001433008 |
| Sale | 2009-12-15 ($12.4 M Offered, $12.4 M Sold) |
| Fund | |
| Phone | 61294928021 |
| Address | Level 1 North Sydney Nsw, 00000 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Peter Campbell | |
| Michael Quinn | |
| Chris Campbell | |
| Warren Stern | |
| John Holaday | |
| Peter Farrell | |
| Gary Pace |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Briggs Chad D.
✚
|
0.0 | |
|
Brisch Donald R.
✚
|
0.0 | |
|
Cannon Fred
✚
|
0.0 | |
|
Canopy Labs Software Inc.
✚
|
0.0 | |
|
Cantara Daniel E
✚
|
0.0 | |
|
Canton Waterfront Restaurant, LLC
✚
|
0.0 | |
|
CA Office Investors Renaissance, LLC
✚
|
0.0 | |
|
Capacho Guillermo A
✚
|
0.0 | |
|
Capezza Joseph C.
✚
|
0.0 | |
|
Canna-Life Corp
✚
|
0.0 |